Gene editing is revolutionizing the understanding of health and disease, providing researchers with vast opportunities to advance the development of novel treatment approaches. Traditionally, ...
Viktor Mamontov, Alexander Martynov, Natalia Morozova, Anton Bukatin, Dmitry B. Staroverov, Konstantin A. Lukyanov, Yaroslav Ispolatov, Ekaterina Semenova, Konstantin Severinov Proceedings of the ...
The growing demand for more rapid high-throughput cell-line development and improved screening in the pharmaceutical space is motivating research facilities and companies to automate their labs.
A glucose-sensitive nanovaccine delivers CRISPR to tumors, silences immune-suppressing genes, and activates a targeted immune response against cancer. (Nanowerk Spotlight) Immune-based cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback